ROSALO PAESTE: Open Payments
NPI 1548349590 · WAIPAHU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 48 payments from 13 companies in 2025. Trend: 2023 $3,357 · 2024 $2,345 · 2025 $1,893
Food & beverage: $1,882Education: $11
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $389 |
| AstraZeneca Pharmaceuticals LP | 10 | $268 |
| Amgen Inc. | 4 | $205 |
| Novo Nordisk Inc | 3 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $165 |
| Gilead Sciences, Inc. | 6 | $162 |
| Lilly USA, LLC | 2 | $128 |
| ANI Pharmaceuticals, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
Products named: JARDIANCE, Ozempic, Repatha, Kerendia, FARXIGA, MOUNJARO, PURIFIED CORTROPHIN GEL, Livdelzi.
Industry payments across HI — which companies pay providers there.
